4//SEC Filing
FLESHNER NEIL E. 4
Accession 0001104659-22-065250
CIK 0001811764other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:05 PM ET
Size
6.8 KB
Accession
0001104659-22-065250
Insider Transaction Report
Form 4
FLESHNER NEIL E.
DirectorChief Medical Officer
Transactions
- Sale
Common Stock
2022-05-25$7.51/sh−564,204$4,237,172→ 3,023,045 total
Holdings
- 358(indirect: By Trust)
Common Stock
- 233,171(indirect: 1510789 Ontario Inc.)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.75, inclusive. The reporting person undertakes to provide to POINT Biopharma Global Inc., any security holder of POINT Biopharma Global Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]A corporation controlled by Reporting Person.
- [F3]A trust, whose trustee is the Reporting Person's spouse.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001868209
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:05 PM ET
- Size
- 6.8 KB